Topoisomerase I/II inhibitor intoplicine administered as a 24-hour infusion: phase I and pharmacologic study

R. van Gijn, W.W. ten Bokkel Huinink, H. Rosing, J.H. Beijnen

Research output: Contribution to journalArticleProfessional

Original languageUndefined/Unknown
Pages (from-to)17-23
Number of pages6
JournalAnti-Cancer Drugs
Volume10
Publication statusPublished - 1999

Cite this